345 related articles for article (PubMed ID: 24050935)
1. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
Lee CM; Cheong SJ; Kim EM; Lim ST; Jeong YY; Sohn MH; Jeong HJ
J Nucl Med; 2013 Nov; 54(11):1974-80. PubMed ID: 24050935
[TBL] [Abstract][Full Text] [Related]
2. Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging.
You DG; Saravanakumar G; Son S; Han HS; Heo R; Kim K; Kwon IC; Lee JY; Park JH
Carbohydr Polym; 2014 Jan; 101():1225-33. PubMed ID: 24299895
[TBL] [Abstract][Full Text] [Related]
3. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
[TBL] [Abstract][Full Text] [Related]
4. Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting.
Muthiah M; Park IK; Cho CS
Biotechnol Adv; 2013 Dec; 31(8):1224-36. PubMed ID: 23528431
[TBL] [Abstract][Full Text] [Related]
5. Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles.
Steitz B; Salaklang J; Finka A; O'Neil C; Hofmann H; Petri-Fink A
Bioconjug Chem; 2007; 18(5):1684-90. PubMed ID: 17718533
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles.
Zolata H; Abbasi Davani F; Afarideh H
Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750
[TBL] [Abstract][Full Text] [Related]
8. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Rosen JE; Chan L; Shieh DB; Gu FX
Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional stable fluorescent magnetic nanoparticles.
Mahmoudi M; Shokrgozar MA
Chem Commun (Camb); 2012 Apr; 48(33):3957-9. PubMed ID: 22422277
[TBL] [Abstract][Full Text] [Related]
10. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
11. Mannose-poly(ethylene glycol)-linked SPION targeted to antigen presenting cells for magnetic resonance imaging on lymph node.
Muthiah M; Vu-Quang H; Kim YK; Rhee JH; Kang SH; Jun SY; Choi YJ; Jeong YY; Cho CS; Park IK
Carbohydr Polym; 2013 Feb; 92(2):1586-95. PubMed ID: 23399193
[TBL] [Abstract][Full Text] [Related]
12. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.
Petri-Fink A; Steitz B; Finka A; Salaklang J; Hofmann H
Eur J Pharm Biopharm; 2008 Jan; 68(1):129-37. PubMed ID: 17881203
[TBL] [Abstract][Full Text] [Related]
13. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
Lam T; Pouliot P; Avti PK; Lesage F; Kakkar AK
Adv Colloid Interface Sci; 2013 Nov; 199-200():95-113. PubMed ID: 23891347
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
Mol Imaging; 2015; 14():. PubMed ID: 26044549
[TBL] [Abstract][Full Text] [Related]
17. Cross-linked magnetic nanoparticles from poly(ethylene glycol) and dodecyl grafted poly(succinimide) as magnetic resonance probes.
Yang HM; Park CW; Lim S; Park SI; Chung BH; Kim JD
Chem Commun (Camb); 2011 Dec; 47(46):12518-20. PubMed ID: 22027959
[TBL] [Abstract][Full Text] [Related]
18. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.
Leuschner C; Kumar CS; Hansel W; Soboyejo W; Zhou J; Hormes J
Breast Cancer Res Treat; 2006 Sep; 99(2):163-76. PubMed ID: 16752077
[TBL] [Abstract][Full Text] [Related]
19. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.
Liao Z; Wang H; Lv R; Zhao P; Sun X; Wang S; Su W; Niu R; Chang J
Langmuir; 2011 Mar; 27(6):3100-5. PubMed ID: 21341768
[TBL] [Abstract][Full Text] [Related]
20. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]